Institutional Ownership
Senti Biosciences Inc
CUSIP 81726A209COM NEWSNTIQ1 2026
13D / 13G Filings
13
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
45.0%
Max % of class reported
Institutional Holders
13
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
13 filings · latest Jan 20, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 20, 2026 | Celadon Partners Spv 24 | 13D/A | 45.0% | — | SEC |
| 2 | Sep 2, 2025 | Celadon Partners Spv 24 | 13D/A | 45.0% | — | SEC |
| 3 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 1.44M | SEC |
| 4 | May 15, 2025 | Nantahala Capital Partners Limited Partnership | 13G/A | 1.9% | 502.5K | SEC |
| 5 | May 15, 2025 | Nantahala Capital Management, LLC | 13G/A | 8.1% | 2.22M | SEC |
| 6 | May 15, 2025 | Nantahala Capital Management, LLC | 13G/A | 8.1% | 2.22M | SEC |
| 7 | Mar 17, 2025 | Celadon Partners Spv 24 | 13D/A | 37.6% | — | SEC |
| 8 | Mar 13, 2025 | Celadon Partners Spv 24 | 13D | 37.6% | — | SEC |
| 9 | Mar 10, 2025 | New Enterprise Associates 15, L.P. | 13D/A | 14.5% | — | SEC |
| 10 | Feb 14, 2025 | Armistice Capital, LLC | 13G | 10.0% | 536.0K | SEC |
3 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Senti Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nea Management Company, LLC | 3.78M | $3.07M |
| 2 | Nantahala Capital Management, LLC | 888.0K | $721.1K |
| 3 | Geode Capital Management, LLC | 207.0K | $168.1K |
| 4 | Menlo Ventures Management, L.P. | 35.7K | $29.0K |
| 5 | Blackrock, Inc. | 25.1K | $20.4K |
| 6 | Xtx Topco Ltd | 17.3K | $14.0K |
| 7 | Northern Trust Corp | 16.8K | $13.6K |
| 8 | State Street Corp | 10.0K | $8.1K |
| 9 | Ubs Group AG | 8.6K | $7.0K |
| 10 | Sbi Securities Co., Ltd. | 334 | $271 |